July 2008

The seeds of CCE were planted nearly three years ago, when some OTN-affiliated physicians decided that they needed to start working more closely together to help advance care in their field. The privately fi nanced company formally started in April 2007.

New genomics-based tests are helping oncologists answer one of the most basic, yet often challenging, questions in cancer care: What kind of cancer does the patient have?

5 Questions with Charles Morris, MD, VP of Worldwide Clinical Research, for Cephalon Oncology.

Many of our patients are using the Internet to look up their diagnoses and medications as soon as they get home from our offices.

We must overcome all of the technical, political, and economical obstacles NOW. The need for system efficiency and patient safety demands it.

A year later, as we read and watch the breathless coverage devoted to recent moves by Google, Microsoft, and Apple, we are left asking "is healthcare IT worth the hype?"